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Amyloid cardiomyopathy is caused by protein deposition in 
the myocardial interstitium, which leads to increased thick- 
ness of the ventricular walls and, eventually, congestive 
heart failure (1,2). The heart failure is often associated with 
normal or mildly reduced ventricular ejection fraction (3) 
and, as such, may be refractory to standard therapies aimed 
at improving systolic function. Although amyloid heart dis- 
ease is commonly referred to as a “restrictive cardiomyop- 
athy,” which implies rapid early ventricular filling followed 
by abrupt restriction to further expansion (4), this character- 
ization is controversial. 
Historical investigation of diastolic function in cardiac 
amyloidosis. For many years it had been suspected that the 
heart failure of amyloid cardiomyopathy was related to the 
thickened, noncompliant ventricular walls found at postmor- 
tem examination. Because amyloid cardiomyopathy exhib- 
ited many of the clinical features of pericardial constriction 
(5,6), clinicians surmised that amyloid-associated heart fail- 
ure was caused by restriction to filling on a myocardial (not 
pericardial) basis. Hemodynamic confirmation of this hy- 
pothesis was provided in 1950 by Fisher et al. (7), who 
performed right heart catheterization on a patient with 
amyloidosis, noting that volume infusion failed to increase 
cardiac output but did increase venous pressure, which 
suggested “mechanical limitations of diastolic filling. . . .” 
Other early reports (8-10) confirmed the hemodynamic sim- 
ilarities between amyloid cardiomyopathy and constrictive 
pericarditis. Both conditions were found to have “dip and 
plateau” or “square root” diastolic ventricular pressure 
patterns that, in combination with the rapid early diastolic 
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“y” descent observed in right atrial pressure forms, sug- 
gested rapid, early diastolic atria1 emptying and ventricular 
filling. The sharp, early to mid-diastolic increase in atria1 and 
ventricular pressures was presumed to be due to abrupt 
restriction of ventricular filling caused by decreased ventric- 
ular or pericardial compliance. 
These early hemodynamic reports went essentially un- 
challenged until Oakley and coworkers (11) contended that 
amyloid heart disease did not meet the criteria for a “re- 
strictive cardiomyopathy.” Instead of the characteristic dip 
and plateau patterns, these investigators found early dias- 
tolic elevations in ventricular pressure that gradually in- 
creased throughout the ventricular filling period. In addition, 
they observed upward shifts of the ventricular pressure- 
volume curves indicating reduced chamber compliance that 
they called “the stiff heart syndrome.” 
Clinical implications of ventricular filling analysis. Al- 
though the argument as to whether myocardial amyloid 
infiltration causes abnormalities in early diastolic ventricular 
filling or, instead, affects passive ventricular chamber stiff- 
ness may initially seem academic, it has potential clinical 
implications. Impairment of early filling could result from 
abnormalities of ventricular relaxation. If these are due to 
biochemical factors such as cellular calcium overload, then 
medical intervention (e.g., administration of calcium channel 
blockers) might improve ventricular relaxation, reduce dias- 
tolic pressure and relieve congestive heart failure. On the 
other hand, if compliance abnormalities are largely respon- 
sible for the heart failure, then effective therapy would 
depend on reversal of the primary infiltrative disease pro- 
cess, an unlikely prospect at present considering the avail- 
able medical armamentarium. 
More recent investigations of the hemodynamics of car- 
diac amyloidosis have not significantly clarified the contro- 
versy. These reports have used various noninvasive cardiac 
imaging techniques to evaluate ventricular diastolic perform- 
ance and have presented seemingly contradictory results, 
not unlike the earlier invasive studies. Whereas some inves- 
tigators (12,13) have noted a consistent pattern of decreased 
rates of early ventricular filling, others (14,1.5) have reported 
normal or increased filling rates similar to those observed in 
pericardial constriction. 
Present study. The present study by Hongo et al. (16) is 
the first to use radionuclide angiography to evaluate diastolic 
function in amyloid heart disease. The major advantage of 
this method is its ability to evaluate global ventricular filling 
without relying on geometric assumptions essential to other 
imaging techniques. Hongo et al. (16) evaluated patients with 
familial amyloid polyneuropathy, most of whom had no 
symptoms of heart disease. They conclude that in the early 
stages of cardiac amyloid infiltration there is a significant 
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reduction in early ventricular filling rates with compensatory 
increments in atrial contribution to late diastolic filling. Their 
results are strengthened by the absence of a “dip and 
plateau” effect in the ventricular pressure tracings of their IO 
catheterized patients. These findings indicate that ventricu- 
lar filling in the early stages of familial amyloid polyneurop- 
athy more closely resembles that described in conditions 
such as hypertrophic cardiomyopathy or myocardial ische- 
mia (17, IX) than that reported in restrictive cardiomyopathy 
(1.5). How then arc we to reconcile the surprising variability 
in reports of amyloid filling patterns and how should amyloid 
diastolic performance be formally classified? 
The spectrum of diastolic performance in cardiac amyloi- 
dosis. An early observation by Meaney et al. (19) may help 
to provide an answer. These workers noted a heterogeneity 
of filling patterns in cardiac amyloidosis. This finding could 
be explained by multiple mechanisms. As Ishida et al. (20) 
have demonstrated, rates of ventricular filling are dependent 
on transmitral pressure gradient dynamics. lntracavitary 
pressure is a product of chamber volume, relaxation, com- 
pliance and external constraint. Because amyloid protein 
can infiltrate almost any cardiac structure, variable chamber 
involvement could result in differential effects on ventricular 
filling patterns. For example. Josselson et al. (21) reported 
atrial involvement in 21 of 29 cases of primary amyloidosis. 
As Gunnar et al. (9) suggested many years ago. a reduction 
in atrial compliance due to amyloid infiltration could lead to 
increased early diastolic atrial pressure. resulting in rapid 
atrial emptying and, therefore, ventricular filling. In addi- 
tion, preliminary investigation (22) with Doppler color flow 
echocardiography has demonstrated a high prevalence of 
mitral regurgitation in primary amyloidosis. Atrial noncom- 
pliance coupled tiith increased atrial volumes from valvular 
regurgitation could significantly elevate early diastolic atrial 
pressure. thereby augmenting transmitral blood flow and 
ventricular filling. Thus, rapid early ventricular filling caused 
by a high atrial driving pressure could mimic the hemody- 
namic pattern of restrictive disease. It is also possible that 
pericardial amyloid infiltration. which has been reported to 
occur (13.21.23). could produce a constrictive influence on 
ventricular filling. further complicating the situation in dias- 
tale. 
Thew is prrlir7linriry cG/ence to confirm the validity of 
this hypoth~tic~~i .swnurio. Cross-sectional analyses of pa- 
tients with primary amyloidosis from our laboratory (3,24) 
and that of others (25) concur with the finding of Hongo et al. 
that early ventricular filling is impeded in the subclinical 
stages of the disease, resulting in a compensatory increment 
in late diastolic filling. However, analysis of ventricular 
filling in patients with more advanced disease indicates that 
early filling rates may pseudonormalize with progressive 
cardiac infiltration. resulting in patterns suggestive of restric- 
tive disease (3.15.25). The latter could result from aug- 
mented early diastolic atrial driving forces as described. 
The data from Hongo et al. (I61 fail to confirm the 
spectrum of filling patterns observed in the aforementioned 
studies. Instead of diastolic pseudonormalization with in- 
creasing duration of disease, they note a further deteriora- 
tion of early filling. It is unclear whether normal patient aging 
or actual disease progression was responsible for this 
finding. Furthermore the study of Hongo et al. (16) does not 
assess the prevalence of mitral regurgitation in the familial 
form of the disease. Because various amyloid protein types 
(prealbumin in familial and immunoglobulin light chains in 
primary disease) may have disease-specific predilections for 
infiltration of cardiac structures (as they do for different 
organ systems). filling patterns could be dependent on pro- 
tein type. A lower prevalence of mitral valve infiltration and 
regurgitation, ah previously reported in familial amyloidosis 
(26). could result in lower early diastolic atrial pressures and 
failure to pseudonormalize early ventricular filling rates. 
Although the mechanisms involved in the diastolic per- 
formance of the amyloid heart are still somewhat specula- 
tive. it does seem clear that the disease may present with 
various ventricular filling profiles and, therefore, should 
probably not be generically categorized in terms of diastolic 
performance. Rather. each patient should be individually 
assessed so that potentially erroneous hemodynamic as- 
sumptions are avoided. 
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